Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.

MLA

Bottet, Florie, et al. “Switch to Abobotulinum Toxin A May Be Useful in the Treatment of Neurogenic Detrusor Overactivity When Intradetrusor Injections of Onabotulinum Toxin A Failed.” Neurourology and Urodynamics, vol. 37, no. 1, Jan. 2018, pp. 291–97. EBSCOhost, https://doi.org/10.1002/nau.23291.

APA

Bottet, F., Peyronnet, B., Boissier, R., Reiss, B., Previnaire, J. G., Manunta, A., Kerdraon, J., Ruffion, A., Lenormand, L., Perrouin Verbe, B., Gaillet, S., Gamé, X., & Karsenty, G. (2018). Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourology and Urodynamics, 37(1), 291–297. https://doi.org/10.1002/nau.23291

Chicago

Bottet, Florie, Benoit Peyronnet, Romain Boissier, Bénédicte Reiss, Jean G Previnaire, Andrea Manunta, Jacques Kerdraon, et al. 2018. “Switch to Abobotulinum Toxin A May Be Useful in the Treatment of Neurogenic Detrusor Overactivity When Intradetrusor Injections of Onabotulinum Toxin A Failed.” Neurourology and Urodynamics 37 (1): 291–97. doi:10.1002/nau.23291.